Baby & children
CeraVe Baby Gentle Bath Wash and Shampoo
CeraVe · owned by L'Oréal S.A.
Infant skin is thinner and more permeable than adult skin, with a higher surface-area-to-weight ratio, so the same product delivers a proportionally larger dose. The American Academy of Pediatrics advises fragrance-free, dye-free products for routine infant care.
Chemistry breakdown
Bar length = weight in the Baby & children formula · color = that component's score · tap a name to learn what it means.
Endocrine disruptorsnone listed · 35% weight
Chemicals that can interfere with the body's hormone system — the signals that regulate growth, metabolism and reproduction. Exposure matters most during pregnancy and early childhood, which is why this component carries extra weight in baby products. Common examples under study: certain parabens, phthalates and bisphenols.
Carcinogensnone listed · 19% weight
Ingredients that authoritative bodies (IARC, US NTP) have classified as known or suspected causes of cancer, weighted by the strength of that evidence — 'possibly carcinogenic' is treated very differently from 'known'.
PFASno PFAS listed · 15% weight
Per- and polyfluoroalkyl substances — 'forever chemicals' that persist in the body and environment for years. Used for water- and stain-resistance; linked in studies to immune and developmental effects.
Materials integrityno materials on file · 13% weight
What the product is physically made of — the pulp, films, fibres and adhesives that touch skin. Rated on the safety record of each material, the way cookware is rated on its coating and metals.
Certificationsnone claimed · 10% weight
Independent third-party verifications (USDA Organic, FSC, EPA Safer Choice…). Informational only — having none never lowers a score; verified claims can raise it.
Fragrance opacityno fragrance listed · 8% weight
US law lets 'fragrance' stand in for dozens of undisclosed chemicals as a trade secret. This measures how much of the scent formula is hidden — not that fragrance is inherently harmful, but that you can't evaluate what isn't disclosed.
Ingredients
We don't have ingredients on file for this product yet.
Made by
- 2022-10Chemical hair-relaxer litigation (MDL 3060) — L'Oréal is among defendants in consolidated federal litigation alleging that chemical hair relaxers contribute to uterine and ovarian cancer, filed after a 2022 NIH Sister Study analysis reported an association with frequent relaxer use. The litigation is UNRESOLVED: no liability finding, and the underlying study is observational and does not establish causation for any specific product. The claims disproportionately concern products marketed to Black women, which is why the matter carries weight beyond its legal posture. Recorded as disputed — an allegation being actively tried, not a finding.